Socioeconomic correlates of antibody levels to enteric pathogens among Israeli adolescents

Epidemiology and Infection

Volumn 135, Issue 1, 2007, Pages 118-125

  Hasin, T ^a,b   Dagan, R ^c   Boutoul, G ^b,d   Derazne, E ^b   Atias, O ^c   Cohen, Dan ^d  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b Military Post   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTOZOON ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD HEALTH; CONTROLLED STUDY; CRYPTOSPORIDIUM PARVUM; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI O157; FEMALE; HEPATITIS A VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; INFECTION RISK; INTESTINE FLORA; ISRAEL; MALE; MICROORGANISM DETECTION; NONHUMAN; PREVALENCE; RADIOIMMUNOASSAY; SCHOOL CHILD; SEROPREVALENCE; SEX DIFFERENCE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SOCIOECONOMICS;

ADOLESCENT; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, PROTOZOAN; CHILD; CRYPTOSPORIDIUM PARVUM; ESCHERICHIA COLI O157; FEMALE; GASTROINTESTINAL DISEASES; HEPATITIS A ANTIBODIES; HEPATITIS A VIRUS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; ISRAEL; MALE; SEROEPIDEMIOLOGIC STUDIES; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SOCIOECONOMIC FACTORS;

EID: 33751356386     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806006455     Document Type: Article

References (27)

1. Dienstag JL, et al. Hepatitis A virus infection: New insights from seroepidemiologic studies. Journal of Infectious Diseases 1978; 137: 328-340.
2. Termorshuizen F, et al. The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: A population-based survey. Epidemiology and Infection 2000; 124: 459-466.
3. Achi R, Mata L, Lindberg AA. Serum antibody titres to Shigella lipopolysaccharides and invasion plasmid antigens in healthy Costa Rican and Swedish women. Scandinavian Journal of Infectious Diseases 1994; 26: 329-337.
4. Cohen D, Slepon R, Green MS. Sociodemographic factors associated with serum anti-Shigella lipopolysaccharide antibodies and shigellosis. International Journal of Epidemiology 1991; 20: 546-550.
5. Chacin-Bonilla L, et al. Cryptosporidium infections in a suburban community in Maracaibo, Venezuela. American Journal of Tropical Medicine and Hygiene 1993; 49: 63-67.
6. Kuhls TL, et al. Seroprevalence of cryptosporidial antibodies during infancy, childhood, and adolescence. Clinical Infectious Diseases 1994; 18: 731-735.
7. Pereira MD, et al. Intra-familial and extra-familial risk factors associated with Cryptosporidium parvum infection among children hospitalized for diarrhea in Goiania, Goias, Brazil. American Journal of Tropical Medicine and Hygiene 2002; 66: 787-793.
8. Cohen D, et al. Natural immunity to shigellosis in two groups with different previous risks of exposure to Shigella is only partly expressed by serum antibodies to lipopolysaccharide. Journal of Infectious Diseases 1992; 165: 785-787.
9. Cohen D, et al. Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections. Journal of Clinical Microbiology 1989; 27: 162-167.
10. Ungar BL, Mulligan M, Nutman TB. Serologic evidence of Cryptosporidium infection in US volunteers before and during Peace Corps service in Africa. Archives of Internal Medicine 1989; 149: 894-897.
11. Robin G, et al. Cryptosporidium infection in Bedouin infants assessed by prospective evaluation of anticryptosporidial antibodies and stool examination. American Journal of Epidemiology 2001; 153: 194-201.
12. Ungar BL, et al. Enzyme immunoassay detection of immunoglobulin M and G antibodies to Cryptosporidium in immunocompetent and immunocompromised persons. Journal of Infectious Dieases 1986; 153: 570-578.
13. Green MS, et al. Sociodemographic correlates of neutralizing poliovirus and hepatitis A virus antibodies as markers of different modes of acquiring immunity. American Journal of Public Health 1990; 80: 1270-1271.
14. Green MS, Zaaide Y. Sibship size as a risk factor for hepatitis A infection. American Journal of Epidemiology 1989; 129: 800-805.
15. Cohen D, et al. Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population. Journal of Infectious Diseases 1988; 157: 1068-1071.
16. Mitchell LA, Zhang T, Tingle AJ. Differential antibody responses to rubella virus infection in males and females. Journal of Infectious Diseases 1992; 166: 1258-1265.
17. Green MS, et al. Sex differences in the humoral antibody response to live measles vaccine in young adults. International Journal of.Epidemiology 1994; 23: 1078-1081.
18. Shohat T, et al. Gender differences in the reactogenicity of measles-mumps-rubella vaccine. Israeli Medical Association Journal 2000; 2: 192-195.
19. Green MS, et al. Four decades of shigellosis in Israel: Epidemiology of a growing public health problem. Review of Infectious Diseases 1991; 13: 248-253.
20. Admoni O, et al. Epidemiological, clinical and microbiological features of shigellosis among hospitalized children in northern Israel. Scandinavian Journal of Infectious Diseases 1995; 27: 139-144.
21. Cohen D, et al. Prospective cohort studies of shigellosis during military field training. European Journal of Clinical Microbiology and Infectious Diseases 2001; 20: 123-126.
22. Greenberg D, et al. Shigella bacteremia: A retrospective study. Clinical Pediatrics (Philadelphia) 2003; 42: 411-415.
23. Finkelman Y, et al. Epidemiology of Shigella infections in two ethnic groups in a geographic region in southern Israel. European Journal of Clinical Microbiology and Infectious Diseases 1994; 13: 367-373.
24. Lerman Y, Slepon R, Cohen D. Epidemiology of acute diarrheal diseases in children in a high standard of living rural settlement in Israel. Pediatric Infectious Disease Journal 1994; 13: 116-122.
25. Fraser D, et al. Natural history of Giardia lamblia and Cryptosporidium infections in a cohort of Israeli Bedouin infants: A study of a population in transition. American Journal of Tropical Medicine and Hygiene 1997; 57: 544-549.
26. Lerman Y, et al. A cluster of cases of Escherichia coli O157 infection in a day-care centre in a communal settlement (Kibbutz) in Israel. Journal of Clinical Microbiology 1992; 30: 520-521.
27. Ludwig K, et al. Immune response to non-O157 Vero toxin-producing Escherichia coli in patients with hemolytic uremic syndrome. Journal of Infectious Diseases 1996; 174: 1028-1039.